Valneva SE (VALN)
7.420
+0.30
(+4.21%)
USD |
NASDAQ |
May 10, 16:00
7.52
+0.10
(+1.35%)
After-Hours: 07:23
Valneva Gross Profit Margin (Quarterly): 37.79% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 37.79% |
September 30, 2023 | 44.91% |
June 30, 2023 | 17.09% |
March 31, 2023 | 38.88% |
December 31, 2022 | -9.26% |
September 30, 2022 | 80.06% |
June 30, 2022 | -120.8% |
March 31, 2022 | 36.56% |
December 31, 2021 | 89.82% |
September 30, 2021 | -458.5% |
June 30, 2021 | 17.12% |
March 31, 2021 | 36.90% |
December 31, 2020 | 62.77% |
September 30, 2020 | -15.12% |
June 30, 2020 | 23.10% |
March 31, 2020 | 63.69% |
December 31, 2019 | 56.76% |
September 30, 2019 | 61.64% |
June 30, 2019 | 44.72% |
March 31, 2019 | 64.91% |
December 31, 2018 | 64.87% |
September 30, 2018 | 57.47% |
Date | Value |
---|---|
June 30, 2018 | 59.15% |
March 31, 2018 | 59.35% |
December 31, 2017 | 53.60% |
September 30, 2017 | 65.74% |
June 30, 2017 | 56.25% |
March 31, 2017 | 53.16% |
December 31, 2016 | 49.69% |
September 30, 2016 | 54.93% |
June 30, 2016 | 66.13% |
March 31, 2016 | 45.59% |
December 31, 2015 | 36.44% |
September 30, 2015 | 50.57% |
June 30, 2015 | 37.89% |
March 31, 2015 | 34.94% |
December 31, 2014 | 39.16% |
September 30, 2014 | 43.78% |
June 30, 2014 | 80.60% |
March 31, 2014 | 62.45% |
December 31, 2013 | 28.73% |
September 30, 2013 | 52.08% |
June 30, 2013 | 49.24% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-458.5%
Minimum
Sep 2021
89.82%
Maximum
Dec 2021
5.69%
Average
37.79%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
DBV Technologies SA | -- |
Cellectis SA | 40.99% |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | -- |
Innate Pharma SA | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -56.33% |
Return on Assets | -18.56% |
Return on Invested Capital | -33.58% |
Profit Margin (Quarterly) | -76.75% |
Operating Margin (Quarterly) | -59.50% |
Return on Net Operating Assets | -30.01% |